AU2003204710A1 - Attenuated microorganisms for the treatment of infection - Google Patents

Attenuated microorganisms for the treatment of infection

Info

Publication number
AU2003204710A1
AU2003204710A1 AU2003204710A AU2003204710A AU2003204710A1 AU 2003204710 A1 AU2003204710 A1 AU 2003204710A1 AU 2003204710 A AU2003204710 A AU 2003204710A AU 2003204710 A AU2003204710 A AU 2003204710A AU 2003204710 A1 AU2003204710 A1 AU 2003204710A1
Authority
AU
Australia
Prior art keywords
infection
treatment
attenuated microorganisms
attenuated
microorganisms
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU2003204710A
Other versions
AU2003204710B2 (en
Inventor
Gordon Dougan
Zoe Hindle
David William Holden
Joseph David Santangelo
Jacqueline Elizabeth Shea
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Emergent Product Development UK Ltd
Original Assignee
Microscience Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU45932/00A external-priority patent/AU763898B2/en
Application filed by Microscience Ltd filed Critical Microscience Ltd
Priority to AU2003204710A priority Critical patent/AU2003204710B2/en
Priority claimed from AU2003204710A external-priority patent/AU2003204710B2/en
Publication of AU2003204710A1 publication Critical patent/AU2003204710A1/en
Application granted granted Critical
Publication of AU2003204710B2 publication Critical patent/AU2003204710B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

AU2003204710A 1999-05-10 2003-06-13 Attenuated microorganisms for the treatment of infection Ceased AU2003204710B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2003204710A AU2003204710B2 (en) 1999-05-10 2003-06-13 Attenuated microorganisms for the treatment of infection

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9910812 1999-05-10
AU45932/00A AU763898B2 (en) 1999-05-10 2000-05-09 Attenuated microorganisms for the treatment of infection
AU2003204710A AU2003204710B2 (en) 1999-05-10 2003-06-13 Attenuated microorganisms for the treatment of infection

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
AU45932/00A Division AU763898B2 (en) 1999-05-10 2000-05-09 Attenuated microorganisms for the treatment of infection

Publications (2)

Publication Number Publication Date
AU2003204710A1 true AU2003204710A1 (en) 2003-07-17
AU2003204710B2 AU2003204710B2 (en) 2006-08-03

Family

ID=39339724

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003204710A Ceased AU2003204710B2 (en) 1999-05-10 2003-06-13 Attenuated microorganisms for the treatment of infection

Country Status (1)

Country Link
AU (1) AU2003204710B2 (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1970449B1 (en) * 1998-09-04 2010-11-03 Emergent Product Development UK Limited Attenuated salmonella SPI2 mutants as antigen carriers

Similar Documents

Publication Publication Date Title
AP2001002317A0 (en) Attenuated microorganisms for the treatment of infection
HUP0203402A3 (en) Enzyme treatment for infection
AU5487800A (en) Fluid treatment system
IL152553A0 (en) Compounds and methods for the treatment and prevention of bacterial infection
ZA200108215B (en) Compositions and methods for treatment of staphylococcal infection.
AU2281601A (en) Treatment of viral infections using levovirinTM
AU2001259507A1 (en) Compounds and methods for the diagnosis and treatment of ehrlichia infection
AU5547000A (en) Novel treatment
NZ513686A (en) Treatment of trauma
AU2021601A (en) Composition for the treatment of dandruff
AU4204700A (en) Compounds and methods for the diagnosis and treatment of (b. microti) infection
AU4556800A (en) Novel treatment
HK1046913A1 (en) Attenuated microorganisms for the treatment of infection
AU2432001A (en) Treatment of mental conditions including depression
AU1878201A (en) Composition for the treatment of damaged tissue
AU1261601A (en) Treatment of C. difficile toxin B associated conditions
AU1772299A (en) Well treatment with microorganisms
AU3311800A (en) Detection of bacterial infection
AU2003263332A1 (en) Wound dressings for the treatment of wound infection
AU1618901A (en) Treatment of rosacea
AU2003204710A1 (en) Attenuated microorganisms for the treatment of infection
AU3759800A (en) Treatment of premenstrual syndrome
AU2002251202A1 (en) Intimins for the prevention or treatment of infections: i
AU2683500A (en) Compositions for the treatment of pain
AU3698199A (en) Radioimmuno-pharmacon for treating the hiv-1 infection